Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 1
1980 1
1981 3
1982 3
1983 5
1984 5
1985 2
1986 8
1987 11
1988 16
1989 10
1990 7
1991 10
1992 11
1993 11
1994 11
1995 19
1996 17
1997 20
1998 25
1999 21
2000 37
2001 45
2002 57
2003 48
2004 77
2005 95
2006 93
2007 120
2008 137
2009 175
2010 200
2011 242
2012 313
2013 345
2014 379
2015 473
2016 510
2017 554
2018 669
2019 767
2020 887
2021 1035
2022 1218
2023 1233
2024 379

Text availability

Article attribute

Article type

Publication date

Search Results

9,203 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Zhang B, Cheng Z, Chen J, Zhang X, Liu D, Jiang H, Ma G, Wang X, Gan S, Sun J, Jin P, Yi J, Shi B, Ma J, Ye S, Wang G, Ji L, Gu X, Yu T, An P, Deng H, Li H, Li L, Ma Q, Qian L, Yang W. Zhang B, et al. Among authors: cheng z. Diabetes Care. 2024 Jan 1;47(1):160-168. doi: 10.2337/dc23-1287. Diabetes Care. 2024. PMID: 37943529 Free PMC article. Clinical Trial.
Carbon-Carbon Bond Cleavage for Late-Stage Functionalization.
Liang YF, Bilal M, Tang LY, Wang TZ, Guan YQ, Cheng Z, Zhu M, Wei J, Jiao N. Liang YF, et al. Among authors: cheng z. Chem Rev. 2023 Nov 22;123(22):12313-12370. doi: 10.1021/acs.chemrev.3c00219. Epub 2023 Nov 9. Chem Rev. 2023. PMID: 37942891 Review.
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma.
Chen X, Liu J, Li Y, Zeng Y, Wang F, Cheng Z, Duan H, Pan G, Yang S, Chen Y, Li Q, Shen X, Li Y, Qin Z, Chen J, Huang Y, Wang X, Lu Y, Shu M, Zhang Y, Wang G, Li K, Lin X, Xing F, Zhang H. Chen X, et al. Among authors: cheng z. Nat Commun. 2023 Oct 25;14(1):6781. doi: 10.1038/s41467-023-42545-3. Nat Commun. 2023. PMID: 37880243 Free PMC article.
The directed evolution of NDM-1.
Thomas CA, Cheng Z, Bethel CR, Hujer AM, Sturgill AM, Onuoha K, Page RC, Bonomo RA, Crowder MW. Thomas CA, et al. Among authors: cheng z. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0071423. doi: 10.1128/aac.00714-23. Epub 2023 Oct 24. Antimicrob Agents Chemother. 2023. PMID: 37874296 Free PMC article.
RNA base editing therapy cures hearing loss induced by OTOF gene mutation.
Xue Y, Tao Y, Wang X, Wang X, Shu Y, Liu Y, Kang W, Chen S, Cheng Z, Yan B, Xie Y, Bi L, Jia H, Li J, Xiao Q, Chen L, Yao X, Shi L, Yang H, Wu H. Xue Y, et al. Among authors: cheng z. Mol Ther. 2023 Dec 6;31(12):3520-3530. doi: 10.1016/j.ymthe.2023.10.019. Epub 2023 Nov 2. Mol Ther. 2023. PMID: 37915172
Concerns about the ALIFE2 trial.
Tang LV, Cheng ZP, Hu Y. Tang LV, et al. Among authors: cheng zp. Lancet. 2024 Jan 20;403(10423):247. doi: 10.1016/S0140-6736(23)02342-5. Lancet. 2024. PMID: 38245244 No abstract available.
Targeting VCP potentiates immune checkpoint therapy for colorectal cancer.
Wang F, Qi Q, Qin B, Wang Y, Huang Y, Li Q, Shen X, Wang X, Yang S, Pan G, Chen J, Qin Z, Chen X, Yang Y, Zeng Y, Liu J, Li Y, Li Y, Cheng Z, Lin X, Xing F, Zhang Y, Wang G, Li K, Jiang Z, Zhang H. Wang F, et al. Among authors: cheng z. Cell Rep. 2023 Nov 28;42(11):113318. doi: 10.1016/j.celrep.2023.113318. Epub 2023 Oct 21. Cell Rep. 2023. PMID: 37865914 Free article.
9,203 results